Recent Finacing
Recent Raise
Newcells Biotech develops iPSC-derived 2D and 3D tissue models (organoids) and provides bespoke assay and testing services for preclinical drug safety, efficacy and pharmacology across retina, kidney and lung.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Newcells Biotech.